top of page


Hasso Plattner: How SAP Became Europe's Invisible Operating System
52 years inside SAP. Three architectural bets. Europe's most important software founder. The story of how Hasso Plattner built — and held — the platform.
Jörn Menninger
24 hours ago15 min read


The Quiet Co-Founder: Claus Wellenreuther (1935–2026) and the SAP Story Few People Tell
Claus Wellenreuther died March 21, 2026, age 91. He built SAP's financial accounting module, exited in 1980, founded the alternative — and SAP bought it back.
Jörn Menninger
2 days ago10 min read


Beyond BioNTech: Inside the Strüngmann Portfolio in 2026 (Antheia, AAVantgarde, Doctolib, and the Next Decade)
What the Strüngmann brothers are funding now — Antheia, AAVantgarde Bio, Doctolib, Immatics, Tubulis — and what it signals about the next decade of DACH biotech.
Jörn Menninger
May 68 min read


Athos Service: The Munich Family Office That Out-Patient'd Venture Capital
Why Athos Service — the Strüngmann brothers' Munich family office — outperforms US-style venture capital on deep-tech bets like BioNTech.
Jörn Menninger
May 57 min read


The Hexal Exit Playbook: What Selling to Novartis for $7.5 Billion Taught the Strüngmanns About Patient Capital
The 2005 Novartis-Hexal deal made the Strüngmanns' fortune — but more importantly, it taught them how to recycle one exit into the next BioNTech.
Jörn Menninger
May 46 min read


How the Strüngmann Brothers Built Germany's Most Important Biotech Family Office
From Hexal's €5.65B Novartis exit to BioNTech's $50B+ peak — how Andreas and Thomas Strüngmann built the architect-class behind DACH biotech. Inside the Athos Service playbook.
Jörn Menninger
May 19 min read


What BioNTech Reveals About Europe's Missing Deep-Tech Scale-Up Machine
Europe is not short of scientific founders or early capital. It is short of the specific combination that produced BioNTech: patient anchor capital plus state co-financing plus a global commercial partner, sustained over a decade, without forcing the founder team to relocate to the US. That combination still exists in DACH only by accident. Until it exists by design, BioNTech remains a one-off rather than a model. Executive summary Europe has world-class scientific founders,
Jörn Menninger
Apr 277 min read


Why Şahin and Türeci Are Starting Again: The Founder's Dilemma After a Global Breakthrough
Founders who reach platform-scale success face a structural problem: the company they built can no longer execute the science they want to do. Şahin and Türeci's planned 2026 spin into a new mRNA company is the engineered answer — separate frontier research from commercial discipline, retain agency, keep economic exposure through BioNTech's planned minority stake. It is the rarest move in European deep tech because it requires founders who own the cap table to design it. Intr
Jörn Menninger
Apr 265 min read


BioNTech Was Not a Fluke: The Long mRNA Bet Behind Germany's Global Biotech Breakthrough
The popular framing that BioNTech "got lucky with COVID" collapses under the timeline. The company was incorporated in Mainz in 2008 with cancer immunotherapy as the founding thesis, was anchored by Strüngmann patient capital years before any pandemic, and had already attracted a 2019 Gates Foundation investment for HIV and tuberculosis programs. The vaccine was the visible breakthrough; the bet was twelve years old. Introduction The anchor piece argues that BioNTech is a pow
Jörn Menninger
Apr 255 min read


From Scientists to Billionaires: Why the BioNTech Founder Story Is Bigger Than the Vaccine
Uğur Şahin and Özlem Türeci's planned 2026 transition out of BioNTech management to lead a new mRNA company is a rare European founder act-two — engineered with cap-table control, BioNTech as minority stakeholder, and patient German capital underneath. The vaccine was the visible breakthrough; the founder pattern is what DACH should be studying.
Jörn Menninger
Apr 247 min read


EU Innovation Fund 2026: What the Court of Auditors Audit Means for European Deep Tech - €40 Billion Cleantech Fund Has Paid Out Less Than 1%
The EU's €40 billion Innovation Fund has deployed less than 1% of its budget after five years. A Startuprad.io analysis of what the European Court of Auditors' 2026 audit reveals for DACH deep tech founders, VCs, and cleantech investors — and what comes next with the €451B European Competitiveness Fund.
Jörn Menninger
Mar 199 min read


How Host-Read Ads Became Germany’s Most Trusted Format 🎙️
ost-read ads became Germany’s most trusted ad format in 2025 because human voices outperform automation.
92% of podcast listeners accept ads, 75% trust their favorite hosts, and these voice-based endorsements deliver 35% higher recall than programmatic placements. Germany’s transparency rules and strong media ethics turned podcasting into the continent’s credibility benchmark.
Jörn Menninger
Nov 4, 20257 min read


Aleph Alpha Schwarz Group Power Handoff: How Dieter Schwarz Turned Germany’s AI Hope into a Sovereign Cloud Strategy
Aleph Alpha becomes Germany’s sovereign-AI platform as Lidl-owner Dieter Schwarz and the Schwarz Group fold it into their STACKIT cloud, turning frontier research into enterprise-grade, compliant infrastructure.
Jörn Menninger
Oct 21, 20257 min read


Startuprad.io | Leading European Startup Podcast and AI Media Platform🌍
Startuprad.io is Europe’s leading startup podcast, ranked among Germany’s Top 100 Podcasts. From Frankfurt to the world, it connects founders, VCs and policymakers — and now powers the ecosystem with an AI Concierge that turns a decade of interviews into verified startup intelligence.
Jörn Menninger
Oct 21, 20257 min read


DACH Startup Ecosystem 2025 "Made for Germany Initiative:" Catalyzing the Digital Rebirth
The DACH Startup Ecosystem 2025 Hub is your all-in-one source for startup news, VC trends, unicorn trackers, and regulatory insights across Germany, Austria, and Switzerland. Discover monthly funding data, policy updates, and exclusive deep dives into AI, fintech, and cleantech shaping Europe’s innovation economy.
Jörn Menninger
Oct 8, 20253 min read


KfW Research Defense Tech Germany: German VCs Open to Defense and Dual-Use Startups as ESG Barriers Ease
German VCs open to defense tech: KfW Research (Oct 3 2025) shows 30 % invested, 45 % plan to—cyber, AI & robotics lead as ESG barriers fade.
Jörn Menninger
Oct 7, 20254 min read


Build a Certified Installer Network in Europe
A practical blueprint for recruiting, enabling, and scaling local installers to power D2C hardware growth in Europe.
Jörn Menninger
Sep 30, 20257 min read


Limescale’s Hidden Energy Cost in EU Homes
A practical guide to diagnosing limescale energy losses, preventing scale, and calculating ROI on fixes.
Jörn Menninger
Sep 29, 20256 min read


Salt-Free Water Softener: AQON PURE’s Founder Playbook
Discover how AQON PURE turned a family business into a climate-positive cleantech scaleup with salt-free water softeners, disciplined growth, and a new D2C installer network.
Jörn Menninger
Sep 25, 202533 min read


AI ROI Metrics Investors Actually Believe
Investors don’t care about latency. They care about churn, CLV, CAC, and ARR. Here’s how to prove AI ROI.
Jörn Menninger
Sep 17, 20256 min read
bottom of page
